CN Patent

CN105541832A — 一种羟乙基磺酸盐帕布昔利布的制备方法

Assigned to NANJING NMG-ADDS Co Ltd · Expires 2016-05-04 · 10y expired

What this patent protects

本发明属于化学药物合成技术领域，具体涉及一种羟乙基磺酸盐帕布昔利布的制备方法，本方法通过4步法制备帕布昔利布即2-(吡啶-2-基氨基)-吡啶并[2,3-d]嘧啶-7-酮羟乙基磺酸盐。本方法工艺条件温和，后处理简单，纯度高，反应成本低，易于实现工业化生产。

USPTO Abstract

本发明属于化学药物合成技术领域，具体涉及一种羟乙基磺酸盐帕布昔利布的制备方法，本方法通过4步法制备帕布昔利布即2-(吡啶-2-基氨基)-吡啶并[2,3-d]嘧啶-7-酮羟乙基磺酸盐。本方法工艺条件温和，后处理简单，纯度高，反应成本低，易于实现工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN105541832A
Jurisdiction
CN
Classification
—
Expires
2016-05-04
Drug substance claim
No
Drug product claim
No
Assignee
NANJING NMG-ADDS Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.